SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-064411
Filing Date
2021-03-02
Accepted
2021-03-02 06:07:13
Documents
2
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d64986d6k.htm 6-K 10338
2 GRAPHIC g64986g45f49.jpg GRAPHIC 28284
  Complete submission text file 0001193125-21-064411.txt   50387
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 21701194
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences